A study finds that consuming grapes twice a day for six months can help in protecting the brain against early decline associated with Alzheimer's disease.
The results showed that a grape-enriched diet protected against the decline of metabolic activity that correlated to improvements in cognition and working memory performance.
Those consuming a grape-enriched diet exhibited increased metabolism in other areas of the brain too.
The research, conducted by the University of California, Los Angeles, was published in Experimental Gerontology.
"The study examines the impact of grapes as a whole fruit versus isolated compounds and the results suggest that regular intake of grapes may provide a protective effect against early decline associated with Alzheimer's disease," said lead investigator of the study Dr. Daniel H. Silverman.
"This pilot study contributes to the growing evidence that supports a beneficial role for grapes in neurologic and cardiovascular health. More clinical studies with larger groups of subjects, however, are needed to confirm the effects observed here," Silverman added.
Participants with early memory decline were randomly selected to receive either whole grape powder - equivalent to just 2 ¼ cups of grapes per day - or a polyphenol-free placebo powder matched for flavour and appearance.
Cognitive performance was measured at baseline and six months later.
Changes in brain metabolism were assessed by brain PET scan as it provides valuable predictive and diagnostic value to clinicians evaluating patients with dementia symptoms.
The results showed that consuming grapes preserved healthy metabolic activity in the regions of the brain that are affected by the earliest stages of Alzheimer's disease, where metabolic decline takes hold.
The researchers also suggest that grapes may help support brain health by working in multiple ways - from reducing oxidative stress in the brain to promoting healthy blood flow in the brain to helping maintain levels of a key brain chemical that promotes memory to exerting anti-inflammatory effects.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
